RESOURCE CENTER
Latest Publications
Hard-earned Insights That Help Drug Manufacturers Achieve Their Growth, Compliance, & Profitability Objectives
Understanding Class of Trade (COT) in Pharma Industry
For pharmaceutical manufacturers, assigning Class of Trade designations to government pricing data can be a tedious exercise. However, it can have large implications on Medicaid rebate liabilities and present compliance risks if not managed correctly. Let’s take a...
Unit Rebate Amount Calculation For Medicaid
How to Calculate A Unit Rebate AmountFor people who regularly work in the pharmaceutical industry within the government pricing space, the question of how a URA is calculated may be one easily answered. For even the most seasoned pharma executives not exposed to...
Pharma Impacts of Unwinding Medicaid Continuous Enrollment
Part I – Unwinding Medicaid Continuous Enrollment May 2022After a slight decline from 2017 to 2019, Medicaid enrollment rose sharply throughout the pandemic. Historically, Medicaid enrollment tracks with unemployment rates. When rates rise, enrollment increases....
Why Prepare Now for 2024 Medicaid Rebate Cap Removal
Reasons to prepare now for the 2024 Medicaid rebate cap removalDoes it feel like proposed Medicaid rule changes are too far in the future to think about? Or the proposed changes appear so dramatic that it seems unlikely to pass into law, so there’s little need to...
Is Wholesale Distribution Right for Drug Makers?
Is wholesale distribution the best option for drug manufacturers?In today’s market, customer mergers and consolidations leave drug manufacturers few options in establishing a distribution strategy to make their products available and remain profitable. The popular...
Why Brand Drug Manufacturers Must Prepare for Final Rules
2023 Final Rule Updates for Drug Manufacturers Originally published March 2022; updated May 2022UPDATE May 18, 2022 2023 was shaping up to be a year of challenging decisions for manufacturers and restricted access to critical pharmaceuticals for patients. The 2023...
Beware Operational Challenges in Medicaid Rebate Processing
Beware of the Many Operational Challenges of Medicaid Rebate ProcessingFor most pharmaceutical manufacturers, participation in the U.S. Federal Medicaid Drug Rebate Program (MDRP) is an important and necessary component of their commercialization...
Letting Some Air Out of the AMP Inflation Penalty
Letting some air out of the AMP inflation penalty.As of late, we have all been bombarded by headlines lamenting or explaining the recent high inflation rates as we consume our daily news. The default reaction to rising inflation is typically in relation to rising...
Why Are My Medicaid Rebate Payments and Processing Rising?
Why Have My Medicaid Rebate Payments and Processing Load Seen Such a Sharp Increase?A look at Medicaid enrollment and what the future may hold.The High Level Story The old adage “Those who choose to ignore history are doomed to repeat it” certainly holds true with...